Doctronic Raises $40 Million In Series B Funding Led By Abstract And Lightspeed Venture Partners

Doctronic has raised $40 million in a Series B funding round led by Abstract and Lightspeed Venture Partners. The investment enables the company to enhance its AI health platform, which initially began as a free AI symptom checker and has since evolved to include $39 telehealth visits with licensed physicians. The funds will support the expansion of services, including the recent pilot program in Utah that allows routine prescription refills under physician oversight.

Summary of transaction details:

• Deal Type: Series B
• Transaction Amount: $40,000,000
• Founders: Matt Pavelle & Dr. Adam Oskowitz
• Headquarters: New York
• Notable Investors: Abstract, Lightspeed Venture Partners, Union Square Ventures, Tusk Ventures, Mantis VC, & Fei-Fei Li

Founded in 2023, Doctronic is co-led by Matt Pavelle and Dr. Adam Oskowitz. The company has garnered attention for its AI-driven healthcare solutions, particularly for its safeguards regarding prescription accuracy and efficacy in aligning with clinician treatment plans. The rising demand for its services highlights the growing interest and scrutiny surrounding AI applications in healthcare.